{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:04:49Z","timestamp":1774559089399,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.diabres.2019.04.034","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T02:58:47Z","timestamp":1557975527000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene"],"prefix":"10.1016","volume":"152","author":[{"given":"Masanori","family":"Iwanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choka","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ito-Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Washiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2019.04.034_b0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gde.2018.02.002","article-title":"Genetic syndromes of severe insulin resistance","volume":"50","author":"Melvin","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.diabres.2019.04.034_b0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF00402277","article-title":"A mutation in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance","volume":"36","author":"Iwanishi","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2019.04.034_b0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diab.41.11.1473","article-title":"Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene","volume":"41","author":"Taylor","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.04.034_b0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2019.04.034_b0025","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db17-0301","article-title":"Structural basis and genotype-phenotype correlations of INSR mutations causing severe insulin resistance","volume":"66","author":"Hosoe","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.04.034_b0030","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","author":"Lotta","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.diabres.2019.04.034_b0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.molmet.2016.05.005","article-title":"Lipodystrophy and severe metabolic dysfunction in mice with adipose tissue-specific insulin receptor ablation","volume":"5","author":"Qiang","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.diabres.2019.04.034_b0040","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2169\/internalmedicine.0225-17","article-title":"Clinical characteristics, phenotype of lipodystropy and genetic analysis of six Japanese female patients with partial lipodystrophy in a diabetic outpatient clinic","volume":"57","author":"Iwanishi","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.diabres.2019.04.034_b0045","article-title":"Clinical characteristics of 15 female Japanese patients with partial lipodystrophy identified in a diabetic outpatient clinic","author":"Iwanishi","year":"2019","journal-title":"Diabetes Updates"},{"key":"10.1016\/j.diabres.2019.04.034_b0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/diab.30.5.387","article-title":"Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp","volume":"30","author":"Greenfield","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.04.034_b0055","first-page":"437","article-title":"A novel technique for the determination of body fat by computed tomography","volume":"7","author":"Tokunaga","year":"1983","journal-title":"Int J Obes"},{"key":"10.1016\/j.diabres.2019.04.034_b0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diacare.39.1.123","article-title":"Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction","volume":"39","author":"Seino","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2019.04.034_b0065","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1093\/emboj\/16.18.5572","article-title":"Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog","volume":"16","author":"Hubbard","year":"1997","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.diabres.2019.04.034_b0070","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/jdi.12829","article-title":"Sex differences in insulin and glucagon responses for glucose homeostasis in young healthy Japanese adults","volume":"9","author":"Horie","year":"2018","journal-title":"J Diabetes Investig"},{"issue":"4","key":"10.1016\/j.diabres.2019.04.034_b0075","first-page":"594","article-title":"Evaluation of partial body composition using bioelectrical in Japanese children","volume":"19","author":"Kubo","year":"2010","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.diabres.2019.04.034_b0080","first-page":"1","article-title":"The diagnosis and management of lipodystrophy syndrome: a multi-society practice guideline","volume":"85","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.04.034_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","article-title":"The clinical approach to the detection of lipodystrophy an AACE consensus statement","volume":"19","author":"Handelsman","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabres.2019.04.034_b0090","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.diabres.2019.04.034_b0095","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophy","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.04.034_b0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/dc07-2194","article-title":"Plasma adiponectin as a marker of insulin receptor dysfunction","volume":"31","author":"Semple","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2019.04.034_b0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","article-title":"SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling","volume":"93","author":"Chudasama","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.diabres.2019.04.034_b0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R 1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"17","key":"10.1016\/j.diabres.2019.04.034_b0115","doi-asserted-by":"crossref","first-page":"e88766","DOI":"10.1172\/jci.insight.88766","article-title":"Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations","volume":"1","author":"Huang-Doran","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.diabres.2019.04.034_b0120","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.metabol.2009.04.043","article-title":"Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy","volume":"58","author":"Iwanishi","year":"2009","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.diabres.2019.04.034_b0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cmet.2016.12.008","article-title":"Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor","volume":"25","author":"Sakaguchi","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2019.04.034_b0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI95476","article-title":"Metreleptin improves insulin sensitivity independent of food intake in humans with lipodystrophy","author":"Brown","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2019.04.034_b0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy onhyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.diabres.2019.04.034_b0140","doi-asserted-by":"crossref","first-page":"E1749","DOI":"10.1210\/jc.2013-2317","article-title":"Metreleptin improves blood glucose in patients with insulin receptor mutations","volume":"98","author":"Brown","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2019.04.034_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/db07-0932","article-title":"High visceral and low abdominal subcutaneous fat stores in the obese adolescent. A determinant of an adverse metabolic phenotype","volume":"57","author":"Taksali","year":"2008","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.diabres.2019.04.034_b0150","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1016\/S0021-9258(18)53063-5","article-title":"Substitution of glutamic acid for alanine 1135 in the putative catalytic loop of the tyrosine kinase domain of the human insulin receptor","volume":"268","author":"Cama","year":"1993","journal-title":"J Bio Chem"},{"key":"10.1016\/j.diabres.2019.04.034_b0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(91)00125-G","article-title":"Protein kinase classification","volume":"200","author":"Hunter","year":"1991","journal-title":"Methods Enzymol"},{"issue":"15","key":"10.1016\/j.diabres.2019.04.034_b0160","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1016\/S0021-9258(19)78131-9","article-title":"Substitution of glutamine for arginine 1131","volume":"269","author":"Kishimoto","year":"1994","journal-title":"J Bio Chem"},{"issue":"49","key":"10.1016\/j.diabres.2019.04.034_b0165","doi-asserted-by":"crossref","first-page":"31019","DOI":"10.1016\/S0021-9258(18)47384-X","article-title":"Two naturally occurring mutations in the kinase domain of insulin receptor accelerate degradation of the insulin receptor and impair the kinase activity","volume":"269","author":"Imamura","year":"1994","journal-title":"J Bio Chem"},{"issue":"12","key":"10.1016\/j.diabres.2019.04.034_b0170","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/mend.13.12.0392","article-title":"Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected cos-7 cells and rat adipose cells","volume":"13","author":"Nystrom","year":"2014","journal-title":"Mol Endo"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719303031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822719303031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T02:54:41Z","timestamp":1663469681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822719303031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":34,"alternative-id":["S0168822719303031"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2019.04.034","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2019.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}